市場調査レポート

商品コード

1707942

遺伝子治療の市場規模、シェア、成長分析、遺伝子タイプ別、治療タイプ別、ベクタータイプ別、送達方法別、投与経路別、用途別、エンドユーザー別、地域別 - 産業予測、2025-2032年

Gene Therapy Market Size, Share, and Growth Analysis, By Gene Type, By Therapy type, By Vector type, By Delivery Method, By Route Of Administration, By Application, By End-user, By Region - Industry Forecast 2025-2032

出版日: 2025年04月08日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 778,888円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,152円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,416円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.96円

全表示
概要
目次

概要

サンプル依頼リストに入れる

遺伝子治療の世界市場規模は2023年に65億米ドルと評価され、2024年の77億4,000万米ドルから2032年には313億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは19.1％で成長する見通しです。

世界の遺伝子治療市場は、ヘルスケアコストの高騰、最先端の医療施設、償還オプションによって上昇傾向にあります。しかし、遺伝子治療薬のコストが高いことが、今後数年間の市場成長をやや妨げる可能性があります。遺伝子治療は、血液疾患、がん、慢性疾患、感染症など様々な疾患に対して、欠陥のある遺伝子を機能的な遺伝子に置き換えるという革新的な治療法です。それは、エイズやパーキンソン病のような症状を治療するために特定の体細胞をターゲットとする体細胞系遺伝子治療と、生殖細胞の遺伝性DNAに影響を与える生殖細胞系遺伝子治療です。治療用遺伝子の送達は、レンチウイルスやアデノウイルスのようなウイルス性ベクターや、リポソームやプラスミドのような非ウイルス性ベクターなどの生物学的ベクターによって促進されます。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Krystal Biotech（USA）
CRISPR Therapeutics（Switzerland）
Intellia Therapeutics（USA）
Beam Therapeutics（USA）
Neurogene（USA）
Prime Medicine（USA）
Taysha Gene Therapies（USA）
Verve Therapeutics（USA）
Voyager Therapeutics（USA）
Korro Bio（USA）
Poseida Therapeutics（USA）
MeiraGTx（USA）
enGene（Canada）
Editas Medicine（USA）
uniQure（Netherlands）
Sangamo Therapeutics（USA）
Generation Bio（USA）
Adverum Biotechnologies（USA）
Benitec Biopharma（USA）

結論と提言

Product Code: SQMIG35H2218

Global Gene Therapy Market size was valued at USD 6.5 billion in 2023 and is poised to grow from USD 7.74 billion in 2024 to USD 31.34 billion by 2032, growing at a CAGR of 19.1% during the forecast period (2025-2032).

The global gene therapy market is on an uptrend, driven by escalating healthcare costs, state-of-the-art healthcare facilities, and reimbursement options. However, the high cost of gene therapies may somewhat hinder market growth in the coming years. Gene therapy is an innovative treatment modality for various diseases, including blood disorders, cancer, chronic illnesses, and infections, by replacing faulty genes with functional ones. It encompasses two primary types: somatic gene therapy, which targets specific body cells to treat conditions like AIDS and Parkinson's, and germline gene therapy, which affects hereditary DNA in reproductive cells. Delivery of therapeutic genes is facilitated by biological vectors, including viral vectors like lentivirus and adenovirus, as well as non-viral options such as liposomes and plasmids.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Therapy Market Segments Analysis

Global Gene Therapy Market is segmented by Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user and region. Based on Gene Type, the market is segmented into Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors and Others. Based on Therapy type, the market is segmented into Gene silencing therapy, Cell replacement therapy, Gene augmentation therapy and Other therapies. Based on Vector type, the market is segmented into Viral vector and Non-Viral Vector. Based on Delivery Method, the market is segmented into Ex-Vivo and In-Vivo. Based on Route Of Administration, the market is segmented into Intravenous Route, Subcutaneous Route and Others. Based on Application, the market is segmented into Oncological Disorders, Cardiovascular Diseases, Infectious Diseases, Hematology, Rare Diseases, Neurological Disorders and Other Diseases. Based on End-user, the market is segmented into Cancer Institutes, Hospitals, Research institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Therapy Market

The global gene therapy market is experiencing significant growth, driven by swift innovations in gene editing technologies like CRISPR-Cas9. These cutting-edge techniques enhance the precision, effectiveness, and safety of genetic modifications, thereby accelerating the clinical development process and expanding treatment options for patients. Furthermore, the use of vector-based methods coupled with improved delivery systems is contributing to the industry's advancement. As a result, the combination of these factors is fostering an environment ripe for breakthroughs in gene therapy, ultimately leading to enhanced therapeutic outcomes and a broader range of solutions for various genetic disorders on a global scale.

Restraints in the Global Gene Therapy Market

The growth of the global gene therapy market is likely to face challenges stemming from various factors, including potential long-term risks, off-target effects, and a host of ethical and safety considerations. These issues could lead to hesitance among the public and regulatory bodies, resulting in a lack of acceptance for new therapies. Such skepticism may deter investment opportunities and impede overall market expansion, as concerns regarding genetic engineering persist. Therefore, overcoming these reservations is essential for fostering confidence in gene therapy developments and ensuring a sustainable trajectory for the industry in the coming years.

Market Trends of the Global Gene Therapy Market

The global gene therapy market is experiencing remarkable growth driven by rapid advancements in genetic research, the rise of innovative treatment methodologies, and an increasing understanding of gene-based therapies. A significant trend is the focus on rare hereditary disorders, as scientists identify genetic defects that underlie these conditions and develop corresponding gene therapies. This shift not only opens new avenues for treatment but also brings hope to patients with previously incurable diseases, fueling demand for targeted and precise therapies. Furthermore, regulatory advancements and increased investment in biotechnology are expected to propel market expansion, solidifying gene therapy's role in modern medicine.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis

Global Gene Therapy Market Size by Gene Type & CAGR (2025-2032)

Market Overview
Antigen
Cytokine
Tumor Suppressor
Suicide
Deficiency
Growth factors
Receptors
Others

Global Gene Therapy Market Size by Therapy type & CAGR (2025-2032)

Market Overview
Gene silencing therapy
Cell replacement therapy
Gene augmentation therapy
Other therapies

Global Gene Therapy Market Size by Vector type & CAGR (2025-2032)

Market Overview
Viral vector
- Retroviral vectors
- AAV Vectors
- Others
Non-Viral Vector
- Oligonucleotide Vectors
- Others

Global Gene Therapy Market Size by Delivery Method & CAGR (2025-2032)

Market Overview
Ex-Vivo
In-Vivo

Global Gene Therapy Market Size by Route Of Administration & CAGR (2025-2032)

Market Overview
Intravenous Route
Subcutaneous Route
Others

Global Gene Therapy Market Size by Application & CAGR (2025-2032)

Market Overview
Oncological Disorders
Cardiovascular Diseases
Infectious Diseases
Hematology
Rare Diseases
Neurological Disorders
Other Diseases

Global Gene Therapy Market Size by End-user & CAGR (2025-2032)

Market Overview
Cancer Institutes
Hospitals
Research institutes
Others

Global Gene Therapy Market Size & CAGR (2025-2032)

North America (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
- US
- Canada
Europe (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Krystal Biotech (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CRISPR Therapeutics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intellia Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beam Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neurogene (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prime Medicine (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taysha Gene Therapies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Verve Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Voyager Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Korro Bio (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Poseida Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MeiraGTx (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
enGene (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Editas Medicine (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
uniQure (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sangamo Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Generation Bio (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adverum Biotechnologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Benitec Biopharma (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

遺伝子治療の市場規模、シェア、成長分析、遺伝子タイプ別、治療タイプ別、ベクタータイプ別、送達方法別、投与経路別、用途別、エンドユーザー別、地域別 - 産業予測、2025-2032年

Gene Therapy Market Size, Share, and Growth Analysis, By Gene Type, By Therapy type, By Vector type, By Delivery Method, By Route Of Administration, By Application, By End-user, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

遺伝子治療市場規模：遺伝子タイプ別

遺伝子治療市場規模：治療のタイプ別

遺伝子治療市場規模：ベクタータイプ別

遺伝子治療市場規模：送達方法別

遺伝子治療市場規模：投与経路別

遺伝子治療市場規模：用途別

遺伝子治療市場規模：エンドユーザー別

遺伝子治療市場規模